Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight contract to search dark genome

.Eli Lilly's look for being overweight aim ats has actually led it to the darker genome. The Big Pha...

ArsenalBio raises $325M, turns away from previous lead possession

.Arsenal Biosciences is carrying on up. The tissue treatment company has added $325 thousand in ammu...

Lilly- supported effective weight loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis make use of medication flunks stage 2b, steering Indivior to reconsider $100M alternative

.Aelis Farma's chances of protecting an easy, good decision on a $one hundred million option remitta...

ProKidney halts phase 3 trial not needed for cell therapy authorization

.ProKidney has stopped some of a set of phase 3 trials for its tissue treatment for kidney health co...

Vaxcyte rises on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals named "stunning" phase 1/2 information for its own 31-valent ...

Recursion's brain illness test reveals little proof of efficacy

.Recursion has actually stumbled with a very early examination of its own tech-enabled approach to m...

Acepodia, Pfizer click on with each other for chemistry-based cell therapy

.Phone it a situation of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scienti...

Praxis epilepsy medicine reduces seizures in stage 2 hearing

.Practice Precision Medicines has actually scored an additional midphase gain in epilepsy this year,...

Three execs surrender as Dyne posts combined records for DMD candidate

.After leaving a medical grip a number of years back, Dyne Rehab has uncovered brand new period 1/2 ...